Search Results 821-830 of 17815 for corticosteroid
... corticosteroids or immunosuppressive agents: NOTE: Inhaled corticosteroids are allowed. One-time antiemetic dose is allowed. Co-morbid systemic illnesses or ...
Participation eligibility · Recent prior chemotherapy: · Requirement for concomitant high dose corticosteroids · Receiving any other investigational agent, which ...
Pituitary apoplexy requires emergency treatment. The treatment usually includes taking corticosteroid medicine to ease swelling around the tumor. You also may ...
... Corticosteroids Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps NCT ID: NCT02898454 POC ID: CLS-20317240; Title: Endogenous Gallbladder ...
Antithymocyte Globulin Use for Corticosteroid Nonresponsive Rejection After Liver Transplantation. Transplant Proc. 2018 Dec; 50 (10):3606-3614 Epub 2018 ...
Corticosteroids ≤2 weeks prior to registration, including oral, IV, subcutaneous, or inhaled routes of administration. NOTE: Patients on chronic ...
... corticosteroid and/or calcineurin inhibitors treatments, have been unsuccessful or not well tolerated, and the patient has a GFR ≥ 45 ml/min/1.73m2, or the ...
Treatment is usually medications that target the immune system and reduce inflammation. Corticosteroids, such as prednisone, are the most common drugs ...
Initiated low-dose corticosteroid ... Patients on a stable low-dose corticosteroid, bisphosphonate, or denosumab regimen are eligible and may continue treatment.
... corticosteroids; Note: use of corticosteroids in doses not exceeding those used for adrenal replacement is acceptable; History of brain metastases; EXCEPTION ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.